I am a
Home I AM A Search Login

Papers of the Week

2020 May 08

Int J Surg Case Rep


Use of Purastat, a novel haemostatic matrix based on self-assembling peptides in the prevention of nasopharyngeal adhesion formation.


Wong E, Ho J, Smith M, Sritharan N, Riffat F, Smith MC
Int J Surg Case Rep. 2020 May 08; 70:227-229.
PMID: 32422584.


Purastat is a novel haemostatic agent that has recently been used effectively in nasal procedures, specifically in functional endoscopic endonasal surgery in the prevention of post-operative epistaxis while minimising adhesion formation. This study presents a case of successful application of Purastat following division of a nasopharyngeal/palatal stenosis following radiotherapy.